American Journal of Respiratory and Critical Care Medicine · 2006 · 84 citations · 48 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationSignal TransductionCytokine BiologyCytokine SignalingIon Channel ExpressionIon Channel PharmacologyIon Channel PhysiologyIon Channel RegulationAirway Epithelial FunctionChloride Channel ConductanceChloride Channel FunctionChloride Channel ModulationChloride Channel PharmacologyChloride Channel PhysiologyChloride Channel SignalingJak-stat Signaling Pathway
RATIONALE: Chloride channels have been implicated in the regulation of mucus production in epithelial cells. Expression of hCLCA1, a calcium-activated chloride channel, has been reported to be increased in the airway epithelium of patients with asthma. Interleukin (IL)-13 induces the cardinal features of bronchial asthma, and glucocorticoids are not sufficient to suppress IL-13-induced airway hyperresponsiveness or goblet cell hyperplasia. OBJECTIVES: We studied the effects of chloride channel inhibitors in IL-13-induced asthma. METHODS: The effects of niflumic acid (NA), a relatively specific blocker of calcium-activated chloride channel (CLCA), on goblet cell hyperplasia, eosinophil accumulation, and airway hyperresponsiveness were evaluated after IL-13 instillation into the airways. Because IL-13-dependent features rely on JAK/STAT6 signaling, the effect of NA on phosphorylation of JAK2 and STAT6 after IL-13 stimulation was examined in airway epithelial cells in vitro. The expression of the mCLCA family in mouse lung after IL-13 local administration in vivo was analyzed using reverse transcription-polymerase chain reaction. MEASUREMENTS AND MAIN RESULTS: Treatment with NA inhibited not only IL-13-induced goblet cell hyperplasia but also airway hyperresponsiveness and eosinophilic infiltration. NA suppressed the eotaxin levels in bronchoalveolar lavage fluids and overexpression of the MUC5AC gene, a marker of goblet cell hyperplasia, in the lung after IL-13 instillation. NA suppressed JAK2 activation, STAT6 activation, and eotaxin expression in epithelial cells. The expression of mCLCA3 (mouse homolog hCLCA1), but not that of other CLCA family members, was up-regulated by IL-13. CONCLUSIONS: These findings suggest that a chloride channel inhibitor can control IL-13-mediated airway features at least by suppressing JAK/STAT6 activation.
48
Interleukin-13: Central Mediator of Allergic Asthma
Marsha Wills‐Karp, Jackie Luyimbazi, Xueying Xu et al. · Science · 1998 · 2.6K citations
Eosinophilic Inflammation in Asthma
Jean Bousquet, Pascal Chanez, Jean Yves Lacoste et al. · New England Journal of Medicine · 1990 · 2.5K citations · Full text
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Gabriele Grünig, Martha L. Warnock, Adil E. Wakil et al. · Science · 1998 · 1.9K citations
SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS
WilliamR. Roche, J H Williams, Richard Beasley et al. · The Lancet · 1989 · 1.1K citations